Abstract
Metastases to the prostate gland are rare and often found in the context of widespread metastatic disease. We report an unusual case of primary gastric signet ring cell adenocarcinoma (SRCC) diagnosed over 1 year after treatment for metastatic disease in the prostate.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Signet Ring Cell / drug therapy
-
Carcinoma, Signet Ring Cell / radiotherapy
-
Carcinoma, Signet Ring Cell / secondary*
-
Humans
-
Immunohistochemistry
-
Male
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / radiotherapy
-
Prostatic Neoplasms / secondary*
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / pathology*
-
Stomach Neoplasms / radiotherapy